Literature DB >> 10648796

Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells.

C Cullinane1, S M Cutts, C Panousis, D R Phillips.   

Abstract

Activation of Adriamycin by formaldehyde leads to the formation of drug-DNA adducts in vitro and these adducts stabilise the DNA to such a degree that they function as virtual interstrand cross-links. The formation of these virtual interstrand cross-links by Adriamycin was investigated in MCF-7 cells using a gene-specific interstrand cross-linking assay. Cross-linking was measured in both the nuclear-encoded DHFR gene and in mitochondrial DNA (mtDNA). Cross-link formation increased linearly with Adriamycin concentration following a 4 h exposure to the drug. The rate of formation of Adriamycin cross-links in each of the genomes was similar, reaching maximal levels of 0.55 and 0.4 cross-links/10 kb in the DHFR gene and mtDNA respectively, following exposure to 20 micro M Adriamycin for 8 h. The interstrand cross-link was short lived in both DNA compartments, with a half-life of 4.5 and 3.3 h in the DHFR gene and mtDNA respectively. The kinetics of total Adriamycin adduct formation, detected using [(14)C]Adriamycin, was similar to that of cross-link formation. Maximal adduct levels (30 lesions/10 kb) were observed following incubation at 20 micro M drug for 8 h. The formation of such high levels of adducts and cross-links could therefore be expected to contribute to the mechanism of action of Adriamycin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648796      PMCID: PMC102585          DOI: 10.1093/nar/28.4.1019

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  Induction of stable transcriptional blockage sites by adriamycin: GpC specificity of apparent adriamycin-DNA adducts and dependence on iron(III) ions.

Authors:  C Cullinane; D R Phillips
Journal:  Biochemistry       Date:  1990-06-12       Impact factor: 3.162

2.  Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.

Authors:  D J Taatjes; G Gaudiano; K Resing; T H Koch
Journal:  J Med Chem       Date:  1996-10-11       Impact factor: 7.446

3.  Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells.

Authors:  P A Speth; P C Linssen; J B Boezeman; J M Wessels; C Haanen
Journal:  J Chromatogr       Date:  1986-04-25

4.  Cytofluorescence detection of adriamycin-mitochondria interactions in isolated, perfused rat heart.

Authors:  K Nicolay; J J Fok; W Voorhout; J A Post; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1986-06-16

5.  Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies.

Authors:  A H Wang; Y G Gao; Y C Liaw; Y K Li
Journal:  Biochemistry       Date:  1991-04-23       Impact factor: 3.162

6.  Comparison of adriamycin uptake in chick embryo heart and liver cells an murine L5178Y lymphoblasts in vitro: role of drug uptake in cardiotoxicity.

Authors:  B A Johnson; M S Cheang; G J Goldenberg
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

7.  Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.

Authors:  G Capranico; C Soranzo; F Zunino
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

8.  DNA sequence-specific adducts of adriamycin and mitomycin C.

Authors:  D R Phillips; R J White; C Cullinane
Journal:  FEBS Lett       Date:  1989-03-27       Impact factor: 4.124

9.  The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes.

Authors:  K Nicolay; R J Timmers; E Spoelstra; R Van der Neut; J J Fok; Y M Huigen; A J Verkleij; B De Kruijff
Journal:  Biochim Biophys Acta       Date:  1984-12-05

10.  Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B.

Authors:  R L Petrusek; G L Anderson; T F Garner; Q L Fannin; D J Kaplan; S G Zimmer; L H Hurley
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

View more
  12 in total

1.  Adriamycin-Induced Models of VACTERL Association.

Authors:  D Mc Laughlin; P Hajduk; P Murphy; P Puri
Journal:  Mol Syndromol       Date:  2013-02

2.  XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.

Authors:  Xiaheng Deng; Xiaolei Zhang; Yidong Cheng; Xiao Yang; Ruizhe Zhao; Xuzhong Liu; Xiao Li; Chao Qin; Qiang Lu; Changjun Yin
Journal:  Tumour Biol       Date:  2015-01-25

3.  Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin.

Authors:  Pengchao Li; Xiaolei Zhang; Xiaheng Deng; Jun Tao; Chao Qin; Xiao Yang; Yidong Cheng; Qiang Lu; Zengjun Wang; Changjun Yin
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 4.  DNA repair deficiency in neurodegeneration.

Authors:  Dennis Kjølhede Jeppesen; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

Review 5.  The Adriamycin rat/mouse model and its importance to the paediatric surgeon.

Authors:  J Gillick; A Mortell; M Dawrant; S Giles; J Bannigan; P Puri
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

6.  Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.

Authors:  Carlotta Sacerdote; Simonetta Guarrera; Fulvio Ricceri; Barbara Pardini; Silvia Polidoro; Alessandra Allione; Rossana Critelli; Alessia Russo; Angeline S Andrew; Yuanqing Ye; Xifeng Wu; Lambertus A Kiemeney; Andrea Bosio; Giovanni Casetta; Giuseppina Cucchiarale; Paolo Destefanis; Paolo Gontero; Luigi Rolle; Andrea Zitella; Dario Fontana; Paolo Vineis; Giuseppe Matullo
Journal:  Int J Cancer       Date:  2013-04-25       Impact factor: 7.396

7.  Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.

Authors:  D Lebrecht; A Geist; U-P Ketelsen; J Haberstroh; B Setzer; U A Walker
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

8.  IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?

Authors:  Birandra K Sinha; Ronald P Mason
Journal:  J Drug Metab Toxicol       Date:  2015-07-24

9.  Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.

Authors:  Kate E Coldwell; Suzanne M Cutts; Ted J Ognibene; Paul T Henderson; Don R Phillips
Journal:  Nucleic Acids Res       Date:  2008-07-16       Impact factor: 16.971

10.  Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposi's sarcoma.

Authors:  Antoinette C van der Kuyl; Remco van den Burg; Fokla Zorgdrager; John T Dekker; Jolanda Maas; Carel J M van Noesel; Jaap Goudsmit; Marion Cornelissen
Journal:  BMC Cancer       Date:  2002-09-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.